Pfizer CEO had dinner with RFK Jr.

Pfizer's CEO says he's had dinner with Trump's health secretary pick, RFK Jr.
Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's "radical" changes.
Pfizer CEO had dinner with RFK Jr.: ‘I’m cautiously optimistic’ in spite of his history with vaccines
Pfizer shares rose early Tuesday due to higher than expected demand for its COVID vaccine, but quickly sunk 2.3% after Kennedy was confirmed.
Robert F. Kennedy had dinner with Pfizer CEO as he prepares to become health secretary, report says
Robert F. Kennedy had dinner with Pfizer CEO as he prepares to become health secretary, report says - Pfizer CEO certain that Trump’s administration ‘will be very, very prudent with everything they tr
Pfizer CEO 'Cautiously Optimistic' As RFK Jr. Advances In Senate
CEO Bourla sees "a lot of opportunities that probably outweigh the risks" with the Trump administration, like working together on cancer treatments
Pfizer CEO: Cautiously optimistic on RFK, Jr. HHS secretary nomination
Pfizer CEO Albert Bourla unpacks the impact of the nomination on 'The Claman Countdown.' Some 10 people killed in attack at Swedish school for adults, gunman believed among dead 20 actors who passed on iconic roles Merck shares plunge as company pauses Gardasil vaccine shipments in China,
RFK Jr. 'tempered' his stance on vaccines in private discussions, Pfizer CEO says
Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health sector.

Pfizer's Retail Traders Cheer Better-Than-Expected Q4

Pfizer’s Covid boost overshadowed by Kennedy threat to vaccines
Pfizer shares, which had risen Tuesday morning after improved demand for the Covid vaccine, dropped 2.3% after Kennedy's ...
Pfizer beats profit estimates on cost cuts, COVID vaccine sales
Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a ...
Crain's New York21h
Pfizer gets unexpected boost from Covid vaccine and pill
Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to ...
Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive The Stock Down
Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...
FiercePharma22h
Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet
After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely ...
Pfizer Inc (PFE) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
Pfizer Inc (PFE) reports robust financial performance with significant revenue growth and strategic progress in oncology and ...
Data4Cure Partners With Pfizer to Deliver New Insights With AI and Data-Driven Knowledge Graphs
Data4Cure today announced an ongoing multi-year partnership with Pfizer, aimed at leveraging advanced analytics and knowledge graph AI to drive innovation in Pfizer’s drug discovery and development ...
Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects growth to accelerate.
Pfizer Inc. shares fell 2% Tuesday despite the drugmaker topping Wall Street’s revenue and profit estimates in its ...